Twist Bioscience Corp (NASDAQ:TWST) shares, rose in value on Friday, July 11, with the stock price down by -1.14% to the previous day’s close as strong demand from buyers drove the stock to $38.03.
Actively observing the price movement in the last trading, the stock closed the session at $38.47, falling within a range of $37.25 and $38.265. The value of beta (5-year monthly) was 2.373. Referring to stock’s 52-week performance, its high was $60.90, and the low was $27.12. On the whole, TWST has fluctuated by 10.39% over the past month.
With the market capitalization of Twist Bioscience Corp currently standing at about $2.28 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-05.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TWST’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of TWST currently trading nearly 4.87% and 13.15% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 58.38, while the 7-day volatility ratio is showing 4.54% which for the 30-day chart, stands at 5.12%. Furthermore, Twist Bioscience Corp (TWST)’s beta value is 2.38.
A comparison of Twist Bioscience Corp (TWST) with its peers suggests the former has fared considerably weaker in the market. TWST showed an intraday change of -1.14% in last session, and over the past year, it shrunk by -18.16%%.
Data on historical trading for Twist Bioscience Corp (NASDAQ:TWST) indicates that the trading volumes over the past 10 days have averaged 0.93 and over the past 3 months, they’ve averaged 1.13 million. According to company’s latest data on outstanding shares, there are 59.86 million shares outstanding.
Nearly 5.39% of Twist Bioscience Corp’s shares belong to company insiders and institutional investors own 110.01% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 10.31 million shares as on 2025-06-13, resulting in a short ratio of 8.51. According to the data, the short interest in Twist Bioscience Corp (TWST) stood at 1943.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 10.62 million. The stock has fallen by -24.69% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TWST stock heading into the next quarter.
